Maxim Group Starts Virpax Pharmaceuticals, Inc. (VRPX) at Buy

June 9, 2022 7:25 AM EDT Send to a Friend
Maxim Group analyst Naz Rahman initiates coverage on Virpax Pharmaceuticals, Inc. (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login